Today: 12 May 2026
US Stock Market Today After the Close: Hot CPI and Oil Reset the AI Rally

US Stock Market Today After the Close: Hot CPI and Oil Reset the AI Rally

New York, May 12, 2026, 16:03 EDT

  • Hotter inflation numbers, surging oil, and a retreat in chip stocks knocked the S&P 500 and Nasdaq off their record highs, putting pressure on a heavily favored trade.
  • April’s CPI climbed 0.6% on the month and 3.8% year-over-year, with energy accounting for over 40% of the monthly gain—leaving rate-cut optimism muted.
  • Bulls can still count on earnings and AI demand. Bears, though, have oil, rising yields, and valuation risk at their backs now.

Wall Street finally lost some altitude after its streak, but the break wasn’t total. The S&P 500 slipped 0.4% from Monday’s peak, while the Nasdaq composite shed 1.2% after its own record high. The Dow Jones Industrial Average managed a 73-point climb, up 0.2%, as tech and semiconductor stocks bore the brunt of the selling.

The chart didn’t just react to “hot” inflation. It was the details: headline CPI jumped 0.6% in April, up 3.8% from a year earlier. Core CPI — stripped of food and energy — climbed 0.4% for the month. Energy did most of the heavy lifting, spiking 3.8% and making up more than 40% of that monthly gain. Oil’s surge hit hard, but traders picked up on some spillover into other categories as well. Bureau of Labor Statistics

This is hitting now because markets had been factoring in a smoother ride: upbeat earnings, softer inflation, and potential Fed cuts ahead. Not what happened. Brent crude surged 3.6% to $107.97 after the U.S.-Iran standoff kept the Strait of Hormuz pretty much closed off, and the 10-year Treasury yield moved up to 4.46% from 4.42%. That uptick means investors want more return to hold government bonds, squeezing pricey growth stocks as their future profits get marked down even harder.

Losses piled up quickest in the markets’ hottest corners. Intel tumbled 8.6%. Micron shed 6.1%. CoreWeave gave up 7.7%, each pulling back after outsized AI-fueled surges earlier this year. Qualcomm, Intel and Sandisk ranked among the worst performers in S&P 500 tech. By the afternoon, the information-technology sector had dropped 2.1%, trailing all other groups in the index’s lineup of 11.

The Fed stuck with its 3.50%-3.75% target range at the April meeting, saying policy would hinge on fresh data. Following the latest CPI, Kalshi’s Fed market pegged “exactly 0 cuts” in 2026 as the likeliest bet—58% odds. Over on Polymarket, traders put zero cuts for 2026 even higher, at 62.5%. As for June, the odds favor no move: nearly 98%. Federal Reserve Kalshi Polymarket Polymarket

The bull argument hasn’t lost its punch. Earnings are delivering. With nearly every S&P 500 company done reporting, 84% have topped profit forecasts—tech led the pack, hitting a 94% beat rate, per DataTrek data cited by Investopedia. Wedbush’s Dan Ives called this earnings run a “wake up call” for anyone doubting AI, adding, “AI adoption is underway.” That view sums up why buyers stuck around. Investopedia

The worry: if oil keeps climbing, the market doesn’t have much room for error. Under Armour’s latest results made that clear—not so much because it moves the S&P, but for the way it illustrates what happens when tariffs, discounting, and wary shoppers squeeze a brand with thin pricing power. Patrick Ricciardi at Third Bridge put it bluntly: raising average selling prices is “becoming harder in a market shaped by tariffs, aggressive promotions and increasingly price-sensitive consumers.” Reuters

Earnings season sorted the field. Zebra Technologies surged, buoyed by a solid first quarter and a boosted outlook. CEO William Burns told investors the company is “moving forward with confidence,” crediting its automation portfolio for helping customers streamline operations. That’s the essential bull case: outfits tied to productivity gains, workflow automation, or AI infrastructure are still showing upside, tougher macro or not. The Motley Fool

On the flip side, Under Armour shares plunged 20% early after the company projected another drop in revenue for the year and set earnings guidance sharply under Wall Street’s forecasts. The brand is grappling with a crowded field—Reuters pointed out intensifying pressure from Nike, Lululemon, and Adidas—as Under Armour works to regain its footing in North America.

The closing bell revealed a deeper divide than index levels alone indicate. Bulls still lean on AI and earnings, yet the inflation data knocked out the straightforward case for rate cuts. That explains the Nasdaq’s steeper loss, with the Dow faring relatively well—investors weren’t bailing across the board, just shedding names most sensitive to rates staying high.

Up next: Cisco steps into the spotlight after Wednesday’s bell. Options are pricing in a swing of close to 8% either direction by Friday—a barometer for whether AI “pick-and-shovel” enthusiasm still balances out those nagging memory costs. CPI drops June 10, followed by the Fed’s rate decision June 16–17. Until then, it’s all about oil’s moves. Investopedia Bureau of Labor Statistics

Stock Market Today

  • Wabash National (WNC) Slides Into Oversold Territory with RSI at 29.2
    May 12, 2026, 5:19 PM EDT. Shares of Wabash National Corp (WNC) fell to a 52-week low of $6.79, pushing its Relative Strength Index (RSI) to 29.2, signaling the stock as oversold according to technical analysis. The RSI, which measures momentum on a scale from 0 to 100, indicates a reading below 30 may suggest selling pressure is peaking. This contrasts with the S&P 500 ETF's high RSI of 78.7. Investors following Warren Buffett's advice might view WNC's current state as a potential buying opportunity amid market fears. WNC's 52-week high stands at $12.94, with the latest trade near the bottom of its range at $6.95.

Latest article

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

12 May 2026
BuzzFeed shares jumped 97% to about $1.44 Tuesday after Byron Allen’s family office agreed to buy 40 million new shares at $3 each, securing 52% control. Only $20 million is due in cash at closing, with the rest as a five-year promissory note. BuzzFeed reported Q1 revenue down 12.4% to $31.6 million and a net loss of $15.1 million. The company warned of “substantial doubt” about its ability to continue operating.
ZoomInfo Stock Sinks as AI Reset Turns a Q1 Beat Into a 2027 Growth Problem
Previous Story

ZoomInfo Stock Sinks as AI Reset Turns a Q1 Beat Into a 2027 Growth Problem

Dow Jones Today: Blue Chips Hold Near 49,700 as Hot CPI Hits Tech and Rate Bets
Next Story

Dow Jones Today: Blue Chips Hold Near 49,700 as Hot CPI Hits Tech and Rate Bets

Go toTop